MedTrace Logo

Assessment of OHIR Score to Predict a Prolonged Intensive Care Unit Stay

NCT02945358 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2017-03-03

No results posted yet for this study

Summary

A prolonged stay in intensive care unit (ICU) after cardiac surgery with cardiopulmonary bypass increases not only cost of patient care but also morbidity and mortality of patients. The ability to predict which patient has the tendency to have a prolonged ICU stay would help in patient and resource management of the hospital. There are many predictive models aiming at identifying patient at risk of prolonged ICU stay after cardiac surgery with cardiopulmonary bypass but almost all involve the preoperative assessment for proper resource management with one model, Open-Heart Intraoperative Risk (OHIR) Scoring concerning intraoperative manipulatable risk factors to improve anesthetic care and patient outcome. The OHIR model comprises 6 risk factors, 5 of which can be managed intraoperatively, with total score of 7 and a score of ≥ 3 indicating a likely prolonged ICU stay. The objective of this study was to re-validate the performance of OHIR score in the recent context.

Conditions

  • ICU Stay

Interventions

PROCEDURE

adult cardiac surgery with cardiopulmonary pump

Open-heart surgery both coronary artery bypass graft (CABG) and valve surgery

Sponsors & Collaborators

  • Khon Kaen University

    lead OTHER

Principal Investigators

  • Sirirat Tribuddharat, MD · Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2017-02-28
Completion
2017-02-28

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02945358 on ClinicalTrials.gov